These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Novel intra-genic large deletions of CTNNB1 gene identified in WT desmoid-type fibromatosis. Colombo C; Urbini M; Astolfi A; Collini P; Indio V; Belfiore A; Paielli N; Perrone F; Tarantino G; Palassini E; Fiore M; Pession A; Stacchiotti S; Pantaleo MA; Gronchi A Genes Chromosomes Cancer; 2018 Oct; 57(10):495-503. PubMed ID: 29901254 [TBL] [Abstract][Full Text] [Related]
5. Human microRNA expression in sporadic and FAP-associated desmoid tumors and correlation with beta-catenin mutations. Cavallini A; Rotelli MT; Lippolis C; Piscitelli D; Digennaro R; Covelli C; Carella N; Accetturo M; Altomare DF Oncotarget; 2017 Jun; 8(26):41866-41875. PubMed ID: 28418912 [TBL] [Abstract][Full Text] [Related]
6. Multifocal occurrence of extra-abdominal desmoid type fibromatosis - A rare manifestation. A clinicopathological study of 6 sporadic cases and 1 hereditary case. Bekers EM; van Broekhoven DLM; van Dalen T; Bonenkamp JJ; van der Geest ICM; de Rooy JWJ; van Gorp JM; Creytens DH; de Leng WWJ; Scheijen B; Eijkelenboom A; Flucke U Ann Diagn Pathol; 2018 Aug; 35():38-41. PubMed ID: 29705714 [TBL] [Abstract][Full Text] [Related]
7. Detection of beta-catenin mutations in paraffin-embedded sporadic desmoid-type fibromatosis by mutation-specific restriction enzyme digestion (MSRED): an ancillary diagnostic tool. Amary MF; Pauwels P; Meulemans E; Roemen GM; Islam L; Idowu B; Bousdras K; Diss TC; O'Donnell P; Flanagan AM Am J Surg Pathol; 2007 Sep; 31(9):1299-309. PubMed ID: 17721184 [TBL] [Abstract][Full Text] [Related]
8. Cutaneous desmoid-type fibromatosis: A rare case with molecular profiling. Aghighi M; Cloutier JM; Hoover WD; Roy K; Lo AA; Brown RA J Cutan Pathol; 2021 Sep; 48(9):1185-1188. PubMed ID: 33978242 [TBL] [Abstract][Full Text] [Related]
9. CTNNB1 45F mutation is a molecular prognosticator of increased postoperative primary desmoid tumor recurrence: an independent, multicenter validation study. Colombo C; Miceli R; Lazar AJ; Perrone F; Pollock RE; Le Cesne A; Hartgrink HH; Cleton-Jansen AM; Domont J; Bovée JV; Bonvalot S; Lev D; Gronchi A Cancer; 2013 Oct; 119(20):3696-702. PubMed ID: 23913621 [TBL] [Abstract][Full Text] [Related]
15. Correlation of CTNNB1 Mutation Status with Progression Arrest Rate in RECIST Progressive Desmoid-Type Fibromatosis Treated with Imatinib: Translational Research Results from a Phase 2 Study of the German Interdisciplinary Sarcoma Group (GISG-01). Kasper B; Gruenwald V; Reichardt P; Bauer S; Hohenberger P; Haller F Ann Surg Oncol; 2016 Jun; 23(6):1924-7. PubMed ID: 26861905 [TBL] [Abstract][Full Text] [Related]
16. Identification of Familial Adenomatous Polyposis carriers among children with desmoid tumours. Kattentidt Mouravieva AA; Geurts-Giele IR; de Krijger RR; van Noesel MM; van de Ven CP; van den Ouweland AM; Kromosoeto JN; Dinjens WN; Dubbink HJ; Smits R; Wagner A Eur J Cancer; 2012 Aug; 48(12):1867-74. PubMed ID: 22305464 [TBL] [Abstract][Full Text] [Related]